scholarly article | Q13442814 |
P356 | DOI | 10.1006/ABBI.2000.2073 |
P698 | PubMed publication ID | 11147835 |
P2093 | author name string | Nelson SD | |
Regal KA | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 47-58 | |
P577 | publication date | 2000-12-01 | |
P1433 | published in | Archives of Biochemistry and Biophysics | Q635818 |
P1476 | title | Orientation of caffeine within the active site of human cytochrome P450 1A2 based on NMR longitudinal (T1) relaxation measurements | |
P478 | volume | 384 |
Q92315774 | Binding Modes and Metabolism of Caffeine |
Q34426453 | CYP2C9 genotype-dependent effects on in vitro drug-drug interactions: switching of benzbromarone effect from inhibition to activation in the CYP2C9.3 variant. |
Q30882779 | Engineering of a water-soluble plant cytochrome P450, CYP73A1, and NMR-based orientation of natural and alternate substrates in the active site |
Q42550924 | Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9. |
Q64934373 | Increased Phenacetin Oxidation upon the L382V Substitution in Cytochrome P450 1A2 is Associated with Altered Substrate Binding Orientation. |
Q35184715 | NMR-derived models of amidopyrine and its metabolites in complexes with rabbit cytochrome P450 2B4 reveal a structural mechanism of sequential N-dealkylation |
Q37429225 | Plasticity of CYP2B enzymes: structural and solution biophysical methods |
Q30561291 | Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism |
Q30396630 | Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR. |
Q42781425 | Structure and function of cytochromes P450 2B: from mechanism-based inactivators to X-ray crystal structures and back |
Q27664259 | Structures of Cytochrome P450 2B4 Complexed with the Antiplatelet Drugs Ticlopidine and Clopidogrel, |
Q37214645 | Substrate binding to cytochromes P450. |
Q40371454 | Substrate proton to heme distances in CYP2C9 allelic variants and alterations by the heterotropic activator, dapsone |
Search more.